Orthofix Medical (NASDAQ:OFIX) Reaches New 12-Month High – Still a Buy?

Shares of Orthofix Medical Inc. (NASDAQ:OFIX) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $17.68 and last traded at $17.56, with a volume of 42318 shares. The stock had previously closed at $16.96.

Orthofix Medical Trading Up 1.0 %

The business has a 50-day moving average of $16.16 and a 200-day moving average of $15.18. The stock has a market capitalization of $682.48 million, a price-to-earnings ratio of -5.55 and a beta of 1.05. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.13 and a current ratio of 2.48.

Orthofix Medical (NASDAQ:OFIX) last announced its earnings results on Tuesday, August 6th. The medical device company reported ($0.88) earnings per share for the quarter, missing the consensus estimate of ($0.30) by ($0.58). Orthofix Medical had a negative net margin of 15.61% and a negative return on equity of 20.68%. The company had revenue of $198.62 million during the quarter, compared to analysts’ expectations of $195.75 million. As a group, research analysts forecast that Orthofix Medical Inc. will post -2.13 EPS for the current year.

Institutional Investors Weigh In On Orthofix Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of OFIX. Price T Rowe Associates Inc. MD increased its holdings in shares of Orthofix Medical by 3.9% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 32,957 shares of the medical device company’s stock valued at $479,000 after purchasing an additional 1,236 shares in the last quarter. AQR Capital Management LLC increased its stake in Orthofix Medical by 4.4% in the 2nd quarter. AQR Capital Management LLC now owns 31,863 shares of the medical device company’s stock valued at $423,000 after purchasing an additional 1,336 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Orthofix Medical by 25.5% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,435 shares of the medical device company’s stock worth $125,000 after purchasing an additional 1,919 shares during the last quarter. nVerses Capital LLC acquired a new stake in Orthofix Medical in the second quarter valued at $27,000. Finally, Victory Capital Management Inc. increased its position in shares of Orthofix Medical by 3.3% in the third quarter. Victory Capital Management Inc. now owns 64,807 shares of the medical device company’s stock valued at $1,012,000 after buying an additional 2,074 shares in the last quarter. Institutional investors and hedge funds own 89.76% of the company’s stock.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.